Skip to main content
Equibles

Man Group plc

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1637460 LONDON, X0
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,386,918
+$4,365,453 QoQ
Shares Held
371,768
+404.1% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#36
of 238 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Man Group plc holds $452,779,482 across 30 Drug Manufacturers - Specialty & Generic names. RDY ranks #13 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,805,003 $129,707,515
2 NBIX
Neurocrine Biosciences Inc
 601,019 $101,295,742
3 UTHR
UNITED THERAPEUTICS Corp
 134,890 $73,087,447
4 VTRS
Viatris Inc
 3,523,052 $55,946,065
5 PRGO
PERRIGO Co plc
 1,530,206 $15,898,840
6 BCRX
Biocryst Pharmaceuticals Inc
 732,867 $7,328,670
7 SUPN
Supernus Pharmaceuticals, Inc.
 156,422 $7,275,186
8 BHC
Bausch Health Companies Inc.
 1,451,781 $7,157,279

All Filings in RDY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,386,918 371,768
2026-03-31 $1,021,465 73,752
2025-12-31 $3,167,409 225,599
2025-06-30 $651,310 43,334
2025-03-31 $983,182 74,540
2024-12-31 $2,478,493 156,966
2024-09-30 $16,568,423 208,539
2024-06-30 $9,186,609 120,575
2024-03-31 $51,753,046 705,563
2023-12-31 $53,242,128 765,193
2023-09-30 $50,279,286 751,896
2023-06-30 $9,812,721 155,486
2023-03-31 $1,977,350 34,733
2022-12-31 $1,797,432 34,733
2022-09-30 $2,146,411 41,009
2022-06-30 $2,277,000 41,109
2022-03-31 $2,575,227 46,209
2021-12-31 $2,505,791 38,309
2021-09-30 $2,645,270 40,609
2021-06-30 $3,007,220 40,909
2021-03-31 $2,928,303 47,700
2020-12-31 $3,243,695 45,500
2020-09-30 $6,406,476 92,100
2020-06-30 $7,764,692 146,476
2020-03-31 $3,798,118 94,176